253 related articles for article (PubMed ID: 25918228)
1. FOXO1 differentially regulates both normal and diabetic wound healing.
Zhang C; Ponugoti B; Tian C; Xu F; Tarapore R; Batres A; Alsadun S; Lim J; Dong G; Graves DT
J Cell Biol; 2015 Apr; 209(2):289-303. PubMed ID: 25918228
[TBL] [Abstract][Full Text] [Related]
2. Foxo1 inhibits diabetic mucosal wound healing but enhances healing of normoglycemic wounds.
Xu F; Othman B; Lim J; Batres A; Ponugoti B; Zhang C; Yi L; Liu J; Tian C; Hameedaldeen A; Alsadun S; Tarapore R; Graves DT
Diabetes; 2015 Jan; 64(1):243-56. PubMed ID: 25187373
[TBL] [Abstract][Full Text] [Related]
3. Dehydroabietic acid reverses TNF-α-induced the activation of FOXO1 and suppression of TGF-β1/Smad signaling in human adult dermal fibroblasts.
Wang XW; Yu Y; Gu L
Int J Clin Exp Pathol; 2014; 7(12):8616-26. PubMed ID: 25674226
[TBL] [Abstract][Full Text] [Related]
4. FOXO1 promotes wound healing through the up-regulation of TGF-β1 and prevention of oxidative stress.
Ponugoti B; Xu F; Zhang C; Tian C; Pacios S; Graves DT
J Cell Biol; 2013 Oct; 203(2):327-43. PubMed ID: 24145170
[TBL] [Abstract][Full Text] [Related]
5. FOXO1 increases CCL20 to promote NF-κB-dependent lymphocyte chemotaxis.
Miao H; Zhang Y; Lu Z; Yu L; Gan L
Mol Endocrinol; 2012 Mar; 26(3):423-37. PubMed ID: 22240809
[TBL] [Abstract][Full Text] [Related]
6. Impaired wound healing in mouse models of diabetes is mediated by TNF-alpha dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1).
Siqueira MF; Li J; Chehab L; Desta T; Chino T; Krothpali N; Behl Y; Alikhani M; Yang J; Braasch C; Graves DT
Diabetologia; 2010 Feb; 53(2):378-88. PubMed ID: 19902175
[TBL] [Abstract][Full Text] [Related]
7. FOXO1 deletion in keratinocytes improves diabetic wound healing through MMP9 regulation.
Zhang C; Lim J; Jeon HH; Xu F; Tian C; Miao F; Hameedaldeen A; Graves DT
Sci Rep; 2017 Sep; 7(1):10565. PubMed ID: 28874756
[TBL] [Abstract][Full Text] [Related]
8. The forkhead transcription factor FOXO1 stimulates the expression of the adipocyte resistin gene.
Liu CW; Yang SY; Lin CK; Liu HS; Ho LT; Wu LY; Lee MJ; Ku HC; Chang HH; Huang RN; Kao YH
Gen Comp Endocrinol; 2014 Jan; 196():41-51. PubMed ID: 24291305
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1.
Kayal RA; Siqueira M; Alblowi J; McLean J; Krothapalli N; Faibish D; Einhorn TA; Gerstenfeld LC; Graves DT
J Bone Miner Res; 2010 Jul; 25(7):1604-15. PubMed ID: 20200974
[TBL] [Abstract][Full Text] [Related]
10. Genistein accelerates refractory wound healing by suppressing superoxide and FoxO1/iNOS pathway in type 1 diabetes.
Tie L; An Y; Han J; Xiao Y; Xiaokaiti Y; Fan S; Liu S; Chen AF; Li X
J Nutr Biochem; 2013 Jan; 24(1):88-96. PubMed ID: 22819564
[TBL] [Abstract][Full Text] [Related]
11. Impact of Diabetes on the Protective Role of FOXO1 in Wound Healing.
Xiao E; Graves DT
J Dent Res; 2015 Aug; 94(8):1025-6. PubMed ID: 25978971
[No Abstract] [Full Text] [Related]
12. FOXO1 expression in keratinocytes promotes connective tissue healing.
Zhang C; Lim J; Liu J; Ponugoti B; Alsadun S; Tian C; Vafa R; Graves DT
Sci Rep; 2017 Feb; 7():42834. PubMed ID: 28220813
[TBL] [Abstract][Full Text] [Related]
13. Reduced FOXO1 expression accelerates skin wound healing and attenuates scarring.
Mori R; Tanaka K; de Kerckhove M; Okamoto M; Kashiyama K; Tanaka K; Kim S; Kawata T; Komatsu T; Park S; Ikematsu K; Hirano A; Martin P; Shimokawa I
Am J Pathol; 2014 Sep; 184(9):2465-79. PubMed ID: 25010393
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated ΔNp63α negatively regulates the maspin promoter in keratinocytes via blocking endogenous p73 binding.
King KE; Reddi DM; Ponnamperuma RM; Gerdes M; Weinberg WC
Mol Carcinog; 2014 Sep; 53(9):698-710. PubMed ID: 23475637
[TBL] [Abstract][Full Text] [Related]
15. FOXO1 regulates VEGFA expression and promotes angiogenesis in healing wounds.
Jeon HH; Yu Q; Lu Y; Spencer E; Lu C; Milovanova T; Yang Y; Zhang C; Stepanchenko O; Vafa RP; Coelho PG; Graves DT
J Pathol; 2018 Jul; 245(3):258-264. PubMed ID: 29574902
[TBL] [Abstract][Full Text] [Related]
16. The cathepsin L gene is a direct target of FOXO1 in skeletal muscle.
Yamazaki Y; Kamei Y; Sugita S; Akaike F; Kanai S; Miura S; Hirata Y; Troen BR; Kitamura T; Nishino I; Suganami T; Ezaki O; Ogawa Y
Biochem J; 2010 Mar; 427(1):171-8. PubMed ID: 20088826
[TBL] [Abstract][Full Text] [Related]
17. FOXO1 regulates wound-healing responses in human gingival fibroblasts.
Rojas L; Tobar N; Espinoza J; Ríos S; Martínez C; Martínez J; Graves DT; Smith PC
J Periodontal Res; 2024 Jun; 59(3):611-621. PubMed ID: 38500269
[TBL] [Abstract][Full Text] [Related]
18. Keratinocyte Function in Normal and Diabetic Wounds and Modulation by FOXO1.
Wang Y; Graves DT
J Diabetes Res; 2020; 2020():3714704. PubMed ID: 33195703
[TBL] [Abstract][Full Text] [Related]
19. Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration.
Mori R; Power KT; Wang CM; Martin P; Becker DL
J Cell Sci; 2006 Dec; 119(Pt 24):5193-203. PubMed ID: 17158921
[TBL] [Abstract][Full Text] [Related]
20. FoxO1 represses LXRα-mediated transcriptional activity of SREBP-1c promoter in HepG2 cells.
Liu X; Qiao A; Ke Y; Kong X; Liang J; Wang R; Ouyang X; Zuo J; Chang Y; Fang F
FEBS Lett; 2010 Oct; 584(20):4330-4. PubMed ID: 20868688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
